Follow us on:
Breaking News
July 29, 2026
Breaking News
Breaking News
ProBio_Webinar_08-27-26_650x90

Reducing Risk in Pharma Product Transfers

 
Reducing Risk in Pharma Product Transfers

Aaron Dely, VP of R&D at PLD Pharma Services, discusses how in-house R&D and analytical support, ANDA strategy, and formulation experience can help pharma companies manage product transfers and avoid costly delays.
Watch Now >>

Headlines

Breaking News
Collaborations & Alliances

ProBioGen Partners with VarmX to Advance Factor X Candidate

The collaboration aims to advance VarmX's Factor X program through cell line development using ProBioGen's proprietary HEK293 host cell line platform.

SPONSOR

Flexibility in Drug Development: From Tactical Response to Strategic Discipline

How strategic flexibility enables continuity, scalability, and reliable execution in modern drug development.

Breaking News

AsymBio Breaks Ground on New Fengxian R&D Building

Strengthens the company’s biologics CDMO capabilities and reinforces the Fengxian site's role as a core development-and-manufacturing hub.

Breaking News
Collaborations & Alliances

Harbour BioMed and Sinopharm Will Establish R&D ‘Innovation Consortium’

The two parties aim to advance collaborative work on innovative biologics.

SPONSOR

Outsourcing Analytical Testing: Balancing Quality, Speed, and Strategic Focus

Benchmark insights from Contract Pharma’s Analytical Testing Survey.

ContractPharma_Conference_2026_650x250

Breaking News
Collaborations & Alliances

ICON to Deploy Claude AI Across Clinical Trial Lifecycle

Multi-year collaboration will apply Claude’s AI capabilities to trial planning, enrollment risk detection, protocol optimization and client integration.

Expert’s Opinion

From Potential to Practical at DIA 2026: A Three-Part Series on Unlocking AI’s Role in Modern Clinical Trials

Reimagining trial design from static protocols to predictive simulation.

Featured Resources

Solution Content Center SPOTLIGHT

AbbVie Contract Manufacturing

Vision. Expertise. Success. AbbVie Contract Manufacturing partners with companies across the globe to develop, scale and manufacture pharmaceutical products and bring them successfully to market. Drawing on more than four decades of success as the manufacturing division of AbbVie, we have the depth of experience and the technical knowledge to navigate issues and deliver the innovative solutions customers need. We are much more than a CMO – we are your partner for success. With foresight, scientific expertise and passion we anticipate the technical and compliance challenges along the entire pharmaceutical development journey through to commercialization. We see the complete picture to deliver our customer's vision. With full access to global state-of the-art facilities and world-class talent, our customers have come to depend on our service and quality to deliver real-world results.

 

Solution Center SPOTLIGHT

Codis

Codis is a global leader in particle processing, delivery technologies and finished dose manufacturing for the nutraceutical, consumer health, OTC, and pharmaceutical sectors. The company provides a wide range of products and services, including formulation development, commercial manufacturing, API development, and packaging. Codis has a proven track record of delivering high-quality GMP products and services that meet the needs of its customers. The company is committed to providing its customers with the highest level of customer service. Visit us at www.codis.com